CN Patent

CN111757739A — 整合应激反应路径抑制剂

Assigned to Praxis Biotechnology Co ltd · Expires 2020-10-09 · 6y expired

What this patent protects

本公开大体上涉及可用作整合应激反应(ISR)路径抑制剂的治疗剂。

USPTO Abstract

本公开大体上涉及可用作整合应激反应(ISR)路径抑制剂的治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111757739A
Jurisdiction
CN
Classification
—
Expires
2020-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Praxis Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.